Ready, Set, Goal: Motivation and Cognition in Stroke Patients

Overview

Apathy is a syndrome of reduced motivation, characterized by diminished goal-directed behaviours (e.g., lack of effort), decreased goal-oriented cognitions (e.g., lack of interest) and blunted affect. Apathy is present in 20-50% of individuals after experiencing a stroke. Despite the detrimental impact of reduced goal-directed behaviours and cognitions on activities of daily living and cognition in stroke patients, interventions for increasing motivation (reducing apathy) have yet to be examined in this population. This study will examine the effect of goal-setting instructions on cognitive performance in stroke patients. The investigators hypothesize that in stroke patients, goal-setting instructions will improve cognitive performance relative to standard instructions. If goal-setting instructions are effective in improving cognitive performance, it may indicate that treatments targeting apathy could serve as a novel way to improve cognitive outcomes and enhance patient quality of life post-stroke.

Full Title of Study: “Ready Set Goal: A Randomized Controlled Trial Examining Motivation and Cognition in Stroke Patients”

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: Randomized
    • Intervention Model: Crossover Assignment
    • Primary Purpose: Other
    • Masking: Single (Participant)
  • Study Primary Completion Date: October 1, 2019

Detailed Description

The study is a single-blind randomized controlled trial. It employs a mixed design, with a between-subjects variable (goal-setting instructions versus standardized instructions) and a within-subjects variable (pre-post instructional manipulation). It is a one-time intervention lasting 1-2 hours. Investigators plan to enroll 72 patients in this study. All participants will complete neuropsychological measures to assess their baseline performance. The baseline measures include Trial 1 of the CVLT-II Alternate Form, the Digit Span Test, Center for Epidemiologic Studies Depression Scale, Controlled Oral Word Association Test, Semantic Fluency Test, Apathy Evaluation Scale and Trail Making Test. After the baseline measures are completed, all participants will rate their level of motivation on a scale from 1 (extremely unmotivated) to 100 (extremely motivated), which will act as a pre-manipulation check measure, their level of fatigue on a scale from 1 (extremely not fatigued) to 100 (extremely fatigued), and their level of anxiety from 1 (extremely not anxious) to 100 (extremely anxious; 1 minute). After completing the baseline measures and rating scales, half (n = 36) of the participants will be randomly assigned to the goal-setting instruction group ("goal-setting group"). Motivation will be enhanced by asking participants to perform 20% better than their previous performance on a similar task, and translating that into a number (e.g., "On this task, you generated 10 words when I asked you to name as many words as you could that start with the letter "F." Now, for the next letter, I want you to generate 12 words."). The remainder of the participants (n = 36) will be assigned to the "standard instruction group," where they will only receive the standardized instructions for completing the tests.

Interventions

  • Behavioral: Goal-Setting Instructions
    • In the goal-setting instruction condition, participants will be asked to increase their performance by 20% from the previous similar test (e.g., “On this task, you generated 10 words when I asked you to name as many words as you could that start with the letter ‘F.’ Now, I want you to aim to generate at least 12 words for the letter ‘F’.”)
  • Behavioral: Standard Instructions
    • Participants in this group will receive the standardized instructions for completing the tests, as outlined in the test appendices.

Arms, Groups and Cohorts

  • Placebo Comparator: Standard Instructions
    • Participants will receive standard instructions for cognitive tasks.
  • Experimental: Goal Setting Instructions
    • Participants will receive goal-setting instructions for cognitive tasks.

Clinical Trial Outcome Measures

Primary Measures

  • Controlled Oral Word Association Task
    • Time Frame: 10 minutes
    • Participant performance on Controlled Oral Word Association Task in goal setting instructions group compared to standard instruction group.

Secondary Measures

  • Motivation Level
    • Time Frame: 2 minutes
    • Participant self-reported motivation level in goal setting instruction group versus standard instruction group.
  • Cognitive Performance on Semantic Fluency Test
    • Time Frame: 10 minutes
    • Participant performance on Semantic Fluency Test in goal setting instructions group compared to standard instruction group.
  • Digit Span Test
    • Time Frame: 10 minutes
    • Participant performance on Digit Span Test in goal setting instructions group compared to standard instruction group.
  • California Verbal Learning Test-II
    • Time Frame: 10 minutes
    • Participant performance on California Verbal Learning Test-II in goal setting instructions group compared to standard instruction group.
  • Trail Making Test
    • Time Frame: 10 minutes
    • Participant performance on Trail Making Test in goal setting instructions group compared to standard instruction group.

Participating in This Clinical Trial

Inclusion Criteria

  • Patient attending Secondary Stroke Prevention Clinic – Ischemic Stroke – Presenting at least 3 months after stroke – Modified Rankin Scale Score of at least 4 – Fluent in English Exclusion Criteria:

  • Marked aphasia – Marked neglect – Severe visual impairment – Inability to complete 1 hour of cognitive testing in English.

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Sunnybrook Health Sciences Centre
  • Collaborator
    • University of Ottawa
  • Provider of Information About this Clinical Study
    • Principal Investigator: Dr. Richard H. Swartz, Principal Investigator – Sunnybrook Health Sciences Centre
  • Overall Official(s)
    • Keera Fishman, B.Sc, Study Director, Sunnybrook Health Sciences Centre/ University of Ottawa

References

Scheurich A, Fellgiebel A, Schermuly I, Bauer S, Wolfges R, Muller MJ. Experimental evidence for a motivational origin of cognitive impairment in major depression. Psychol Med. 2008 Feb;38(2):237-46. doi: 10.1017/S0033291707002206. Epub 2007 Nov 16.

REITAN RM. The relation of the trail making test to organic brain damage. J Consult Psychol. 1955 Oct;19(5):393-4. doi: 10.1037/h0044509. No abstract available.

Darvesh S, Leach L, Black SE, Kaplan E, Freedman M. The behavioural neurology assessment. Can J Neurol Sci. 2005 May;32(2):167-77. doi: 10.1017/s0317167100003930.

Delis, D. C., Kramer, J. H, Kaplan, E., & Ober, B. A. (2000). California Verbal Learning Test – Second edition. Adult version: Manual. San Antonio: Psychological Corporation.

Benton, A. L., & Hamsher, K. (1976). Multilingual Aphasia Examination. Iowa City, Iowa: University of Iowa.

Wechsler, D. (2008). Wechsler Adult Intelligence Scale-Fourth Edition. San Antonio, TX: Pearson.

Marin RS. Apathy: a neuropsychiatric syndrome. J Neuropsychiatry Clin Neurosci. 1991 Summer;3(3):243-54. doi: 10.1176/jnp.3.3.243.

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.